Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

A Toll-like receptor 2 genetic variant modulates occurrence of bacterial infections in patients with sickle cell disease.

Tozatto-Maio K, Girot R, Ly ID, Rocha V, Silva Pinto AC, Diagne I, Benzerara Y, Dinardo CL, Kashima S, Leston-Araujo I, Kenzey C, Fonseca GHH, Rodrigues ES, Volt F, Jarduli LR, Ruggeri A, Mariaselvam CM, Gualandro SFM, Elayoubi H, Cunha R, Cappelli B, Malmegrim KCR, Simões BP, Gluckman E, Tamouza R.

Br J Haematol. 2019 Jun;185(5):918-924. doi: 10.1111/bjh.15875. Epub 2019 Mar 25.

PMID:
30908604
2.

No genetic relationship between TLR2 rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations.

Semlali A, Almutairi M, Parine NR, Al Amri A, Shaik JP, Al Naeem A, Abdulla Ajaj S, Rouabhia M, Alanazi MS.

Onco Targets Ther. 2017 Apr 27;10:2325-2333. doi: 10.2147/OTT.S121618. eCollection 2017.

3.

Single-nucleotide polymorphisms in the Toll-like receptor pathway increase susceptibility to infections in severely injured trauma patients.

Bronkhorst MW, Boyé ND, Lomax MA, Vossen RH, Bakker J, Patka P, Van Lieshout EM.

J Trauma Acute Care Surg. 2013 Mar;74(3):862-70. doi: 10.1097/TA.0b013e31827e1534.

PMID:
23425749
4.

Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis.

Nischalke HD, Berger C, Aldenhoff K, Thyssen L, Gentemann M, Grünhage F, Lammert F, Nattermann J, Sauerbruch T, Spengler U, Appenrodt B.

J Hepatol. 2011 Nov;55(5):1010-6. doi: 10.1016/j.jhep.2011.02.022. Epub 2011 Feb 26.

PMID:
21356257
5.

Variants in the non-coding region of the TLR2 gene associated with infectious subphenotypes in pediatric sickle cell anemia.

David S, Aguiar P, Antunes L, Dias A, Morais A, Sakuntabhai A, Lavinha J.

Immunogenetics. 2018 Jan;70(1):37-51. doi: 10.1007/s00251-017-1013-7. Epub 2017 Jun 30.

6.

Susceptibility to paratuberculosis infection in cattle is associated with single nucleotide polymorphisms in Toll-like receptor 2 which modulate immune responses against Mycobacterium avium subspecies paratuberculosis.

Koets A, Santema W, Mertens H, Oostenrijk D, Keestra M, Overdijk M, Labouriau R, Franken P, Frijters A, Nielen M, Rutten V.

Prev Vet Med. 2010 Mar 1;93(4):305-15. doi: 10.1016/j.prevetmed.2009.11.008. Epub 2009 Dec 14.

PMID:
20005587
7.

Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.

Pine SO, McElrath MJ, Bochud PY.

AIDS. 2009 Nov 27;23(18):2387-95. doi: 10.1097/QAD.0b013e328330b489.

8.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
9.

The polymorphism rs4696480 in the TLR2 gene is associated with psoriasis patients in the Turkish population.

Sabah-Özcan S, Gürel G.

Immunol Lett. 2019 Jul;211:28-32. doi: 10.1016/j.imlet.2019.05.008. Epub 2019 May 21.

PMID:
31125591
10.

A case-control study of innate immunity pathway gene polymorphisms in Puerto Ricans reveals association of toll-like receptor 2 +596 variant with asthma.

Ortiz-Martínez MG, Frías-Belén O, Nazario-Jiménez S, López-Quintero M, Rodríguez-Cotto RI, Jiménez-Vélez BD.

BMC Pulm Med. 2016 Aug 5;16(1):112. doi: 10.1186/s12890-016-0272-7.

11.

TLR2 polymorphisms influence neonatal regulatory T cells depending on maternal atopy.

Liu J, Rädler D, Illi S, Klucker E, Turan E, von Mutius E, Kabesch M, Schaub B.

Allergy. 2011 Aug;66(8):1020-9. doi: 10.1111/j.1398-9995.2011.02573.x. Epub 2011 Mar 4.

PMID:
21371045
12.

[Changes and clinical significance of Toll-like receptor 2 and 4 expression in neonatal infections].

Zhang JP, Chen C, Yang Y.

Zhonghua Er Ke Za Zhi. 2007 Feb;45(2):130-3. Chinese.

PMID:
17456342
13.

Toll-like receptor 9 polymorphisms are associated with severity variables in a cohort of meningococcal meningitis survivors.

Sanders MS, van Well GT, Ouburg S, Morré SA, van Furth AM.

BMC Infect Dis. 2012 May 11;12:112. doi: 10.1186/1471-2334-12-112.

14.

Identification of single nucleotide polymorphisms in Toll-like receptor candidate genes associated with tuberculosis infection in water buffalo (Bubalus bubalis).

Alfano F, Peletto S, Lucibelli MG, Borriello G, Urciuolo G, Maniaci MG, Desiato R, Tarantino M, Barone A, Pasquali P, Acutis PL, Galiero G.

BMC Genet. 2014 Dec 14;15:139. doi: 10.1186/s12863-014-0139-y.

15.

Association of a single nucleotide polymorphism in the TLR2 gene (rs3804099), but not in the TLR4 gene (rs4986790), with Helicobacter pylori infection and peptic ulcer.

Mirkamandar E, Nemati M, Hayatbakhsh MM, Bassagh A, Khosravimashizi A, Jafarzadeh A.

Turk J Gastroenterol. 2018 May;29(3):283-291. doi: 10.5152/tjg.2018.17484.

16.

Genetic polymorphisms in Toll-like receptors among pediatric patients with renal parenchymal infections of different clinical severities.

Cheng CH, Lee YS, Chang CJ, Lin TY.

PLoS One. 2013;8(3):e58687. doi: 10.1371/journal.pone.0058687. Epub 2013 Mar 4.

17.

Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection.

Bochud PY, Hersberger M, Taffé P, Bochud M, Stein CM, Rodrigues SD, Calandra T, Francioli P, Telenti A, Speck RF, Aderem A; Swiss HIV Cohort Study.

AIDS. 2007 Feb 19;21(4):441-6.

PMID:
17301562
18.

Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma.

Kerkhof M, Postma DS, Brunekreef B, Reijmerink NE, Wijga AH, de Jongste JC, Gehring U, Koppelman GH.

Thorax. 2010 Aug;65(8):690-7. doi: 10.1136/thx.2009.119636.

PMID:
20685742
19.

Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women.

Wujcicka W, Paradowska E, Studzińska M, Wilczyński J, Nowakowska D.

Virol J. 2017 Mar 24;14(1):64. doi: 10.1186/s12985-017-0730-8.

20.

The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.

Nischalke HD, Coenen M, Berger C, Aldenhoff K, Müller T, Berg T, Krämer B, Körner C, Odenthal M, Schulze F, Grünhage F, Nattermann J, Sauerbruch T, Spengler U.

Int J Cancer. 2012 Mar 15;130(6):1470-5. doi: 10.1002/ijc.26143. Epub 2011 Jun 18.

Supplemental Content

Support Center